4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-062035
Chief Executive Officer sold 83,333 shares at $63.50 ($5,291,646)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2019-12-24 | Sale | −83,333 | $63.50 | $5,291,646 | 1,805,237 | D |
| Open-market sales · 83,333 sh · avg $63.50 · $5,291,646 | |||||||
Loading xslF345X03/doc4.xml…